Children’s Hospital of Philadelphia Study Reveals Novel Immune-Based Biomarker Helps Detect Ovarian Cancer Two to Four Years Before Conventional Diagnosis

Study Highlights Hospital’s Commitment to Lifespan Research PHILADELPHIA, June 14, 2024 /PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) announced the discovery of a novel immune-based biomarker that could pave the way for potential lifesaving early detection of…